Cargando…

Extracellular Vesicle-Mediated IL-1 Signaling in Response to Doxorubicin Activates PD-L1 Expression in Osteosarcoma Models

The expression of programmed cell death ligand 1 (PD-L1) in tumors is associated with tumor cell escape from T-cell cytotoxicity, and is considered a crucial effector in chemoresistance and tumor relapse. Although PD-L1 induction has been observed in patients after chemotherapy treatment, the mechan...

Descripción completa

Detalles Bibliográficos
Autores principales: Yati, Su, Silathapanasakul, Atiruj, Thakaeng, Chakrarin, Chanasakulniyom, Mayuree, Songtawee, Napat, Porntadavity, Sureerut, Pothacharoen, Peraphan, Pruksakorn, Dumnoensun, Kongtawelert, Prachya, Yenchitsomanus, Pa-thai, Chanmee, Theerawut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946890/
https://www.ncbi.nlm.nih.gov/pubmed/35326493
http://dx.doi.org/10.3390/cells11061042
_version_ 1784674299727052800
author Yati, Su
Silathapanasakul, Atiruj
Thakaeng, Chakrarin
Chanasakulniyom, Mayuree
Songtawee, Napat
Porntadavity, Sureerut
Pothacharoen, Peraphan
Pruksakorn, Dumnoensun
Kongtawelert, Prachya
Yenchitsomanus, Pa-thai
Chanmee, Theerawut
author_facet Yati, Su
Silathapanasakul, Atiruj
Thakaeng, Chakrarin
Chanasakulniyom, Mayuree
Songtawee, Napat
Porntadavity, Sureerut
Pothacharoen, Peraphan
Pruksakorn, Dumnoensun
Kongtawelert, Prachya
Yenchitsomanus, Pa-thai
Chanmee, Theerawut
author_sort Yati, Su
collection PubMed
description The expression of programmed cell death ligand 1 (PD-L1) in tumors is associated with tumor cell escape from T-cell cytotoxicity, and is considered a crucial effector in chemoresistance and tumor relapse. Although PD-L1 induction has been observed in patients after chemotherapy treatment, the mechanism by which the drug activates PD-L1 expression remains elusive. Here, we identified the extracellular vesicles (EVs) as a molecular mediator that determines the effect of doxorubicin on PD-L1 expression in osteosarcoma models. Mechanistically, doxorubicin dependently stimulates the release of extracellular vesicles, which mediate autocrine/paracrine signals in osteosarcoma cells. The recipient cells were stimulated by these EVs and acquired the ability to promote the expression of inflammatory cytokines interleukin (IL)-1β and IL-6. In response to doxorubicin, IL-1β, but not IL-6, allowed- osteosarcoma cells to promote the expression of PD-L1, and the elimination of IL-1β/IL-1 receptor signaling with IL-1 receptor antagonist reduced PD-L1 expression. Together, these findings provided insights into the role of EV release in response to chemotherapy that mediates PD-L1 expression via the IL-1 signaling pathway, and suggested that the combination of a drug targeting IL-1 or PD-L1 with chemotherapy could be an effective treatment option for osteosarcoma patients.
format Online
Article
Text
id pubmed-8946890
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89468902022-03-25 Extracellular Vesicle-Mediated IL-1 Signaling in Response to Doxorubicin Activates PD-L1 Expression in Osteosarcoma Models Yati, Su Silathapanasakul, Atiruj Thakaeng, Chakrarin Chanasakulniyom, Mayuree Songtawee, Napat Porntadavity, Sureerut Pothacharoen, Peraphan Pruksakorn, Dumnoensun Kongtawelert, Prachya Yenchitsomanus, Pa-thai Chanmee, Theerawut Cells Article The expression of programmed cell death ligand 1 (PD-L1) in tumors is associated with tumor cell escape from T-cell cytotoxicity, and is considered a crucial effector in chemoresistance and tumor relapse. Although PD-L1 induction has been observed in patients after chemotherapy treatment, the mechanism by which the drug activates PD-L1 expression remains elusive. Here, we identified the extracellular vesicles (EVs) as a molecular mediator that determines the effect of doxorubicin on PD-L1 expression in osteosarcoma models. Mechanistically, doxorubicin dependently stimulates the release of extracellular vesicles, which mediate autocrine/paracrine signals in osteosarcoma cells. The recipient cells were stimulated by these EVs and acquired the ability to promote the expression of inflammatory cytokines interleukin (IL)-1β and IL-6. In response to doxorubicin, IL-1β, but not IL-6, allowed- osteosarcoma cells to promote the expression of PD-L1, and the elimination of IL-1β/IL-1 receptor signaling with IL-1 receptor antagonist reduced PD-L1 expression. Together, these findings provided insights into the role of EV release in response to chemotherapy that mediates PD-L1 expression via the IL-1 signaling pathway, and suggested that the combination of a drug targeting IL-1 or PD-L1 with chemotherapy could be an effective treatment option for osteosarcoma patients. MDPI 2022-03-18 /pmc/articles/PMC8946890/ /pubmed/35326493 http://dx.doi.org/10.3390/cells11061042 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Yati, Su
Silathapanasakul, Atiruj
Thakaeng, Chakrarin
Chanasakulniyom, Mayuree
Songtawee, Napat
Porntadavity, Sureerut
Pothacharoen, Peraphan
Pruksakorn, Dumnoensun
Kongtawelert, Prachya
Yenchitsomanus, Pa-thai
Chanmee, Theerawut
Extracellular Vesicle-Mediated IL-1 Signaling in Response to Doxorubicin Activates PD-L1 Expression in Osteosarcoma Models
title Extracellular Vesicle-Mediated IL-1 Signaling in Response to Doxorubicin Activates PD-L1 Expression in Osteosarcoma Models
title_full Extracellular Vesicle-Mediated IL-1 Signaling in Response to Doxorubicin Activates PD-L1 Expression in Osteosarcoma Models
title_fullStr Extracellular Vesicle-Mediated IL-1 Signaling in Response to Doxorubicin Activates PD-L1 Expression in Osteosarcoma Models
title_full_unstemmed Extracellular Vesicle-Mediated IL-1 Signaling in Response to Doxorubicin Activates PD-L1 Expression in Osteosarcoma Models
title_short Extracellular Vesicle-Mediated IL-1 Signaling in Response to Doxorubicin Activates PD-L1 Expression in Osteosarcoma Models
title_sort extracellular vesicle-mediated il-1 signaling in response to doxorubicin activates pd-l1 expression in osteosarcoma models
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946890/
https://www.ncbi.nlm.nih.gov/pubmed/35326493
http://dx.doi.org/10.3390/cells11061042
work_keys_str_mv AT yatisu extracellularvesiclemediatedil1signalinginresponsetodoxorubicinactivatespdl1expressioninosteosarcomamodels
AT silathapanasakulatiruj extracellularvesiclemediatedil1signalinginresponsetodoxorubicinactivatespdl1expressioninosteosarcomamodels
AT thakaengchakrarin extracellularvesiclemediatedil1signalinginresponsetodoxorubicinactivatespdl1expressioninosteosarcomamodels
AT chanasakulniyommayuree extracellularvesiclemediatedil1signalinginresponsetodoxorubicinactivatespdl1expressioninosteosarcomamodels
AT songtaweenapat extracellularvesiclemediatedil1signalinginresponsetodoxorubicinactivatespdl1expressioninosteosarcomamodels
AT porntadavitysureerut extracellularvesiclemediatedil1signalinginresponsetodoxorubicinactivatespdl1expressioninosteosarcomamodels
AT pothacharoenperaphan extracellularvesiclemediatedil1signalinginresponsetodoxorubicinactivatespdl1expressioninosteosarcomamodels
AT pruksakorndumnoensun extracellularvesiclemediatedil1signalinginresponsetodoxorubicinactivatespdl1expressioninosteosarcomamodels
AT kongtawelertprachya extracellularvesiclemediatedil1signalinginresponsetodoxorubicinactivatespdl1expressioninosteosarcomamodels
AT yenchitsomanuspathai extracellularvesiclemediatedil1signalinginresponsetodoxorubicinactivatespdl1expressioninosteosarcomamodels
AT chanmeetheerawut extracellularvesiclemediatedil1signalinginresponsetodoxorubicinactivatespdl1expressioninosteosarcomamodels